221 related articles for article (PubMed ID: 28162850)
1. Examination of the Hepatitis C Virus care continuum among individuals with an opioid use disorder in substance use treatment.
Brown JL; Gause NK; Lewis D; Winhusen T
J Subst Abuse Treat; 2017 May; 76():77-80. PubMed ID: 28162850
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C Virus Testing and Treatment Among Persons Receiving Buprenorphine in an Office-Based Program for Opioid Use Disorders.
Carey KJ; Huang W; Linas BP; Tsui JI
J Subst Abuse Treat; 2016 Jul; 66():54-9. PubMed ID: 26988423
[TBL] [Abstract][Full Text] [Related]
3. Utilization of buprenorphine and methadone among opioid users who inject drugs.
Tsui JI; Burt R; Thiede H; Glick SN
Subst Abus; 2018 Jan; 39(1):83-88. PubMed ID: 28796591
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C Virus (HCV) Care Continuum Outcomes and HCV Community Viral Loads Among Patients in an Opioid Treatment Program.
Jordan AE; Cleland CM; Schackman BR; Wyka K; Perlman DC; Nash D
J Infect Dis; 2020 Sep; 222(Suppl 5):S335-S345. PubMed ID: 32877560
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C Virus Screening among Medicaid-Insured Individuals with Opioid Use Disorder across Substance Use Disorder Treatment Settings.
Choi S; Healy S; Shapoval L; Forthal S; Neighbors CJ
Subst Use Misuse; 2021; 56(2):258-263. PubMed ID: 33345680
[No Abstract] [Full Text] [Related]
6. Hepatitis C virus infection and pain sensitivity in patients on methadone or buprenorphine maintenance therapy for opioid use disorders.
Tsui JI; Lira MC; Cheng DM; Winter MR; Alford DP; Liebschutz JM; Mao J; Edwards RR; Samet JH
Drug Alcohol Depend; 2015 Aug; 153():286-92. PubMed ID: 26048638
[TBL] [Abstract][Full Text] [Related]
7. Effect of an mHealth Intervention on Hepatitis C Testing Uptake Among People With Opioid Use Disorder: Randomized Controlled Trial.
Hochstatter KR; Gustafson DH; Landucci G; Pe-Romashko K; Cody O; Maus A; Shah DV; Westergaard RP
JMIR Mhealth Uhealth; 2021 Feb; 9(2):e23080. PubMed ID: 33616545
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C Cascade of Care Among Pregnant Women on Opioid Agonist Pharmacotherapy Attending a Comprehensive Prenatal Program.
Page K; Leeman L; Bishop S; Cano S; Bakhireva LN
Matern Child Health J; 2017 Sep; 21(9):1778-1783. PubMed ID: 28699096
[TBL] [Abstract][Full Text] [Related]
9. Age related medication for addiction treatment (MAT) use for opioid use disorder among Medicaid-insured patients in New York.
Neighbors CJ; Choi S; Healy S; Yerneni R; Sun T; Shapoval L
Subst Abuse Treat Prev Policy; 2019 Jun; 14(1):28. PubMed ID: 31238952
[TBL] [Abstract][Full Text] [Related]
10. Influence of social determinants of health and substance use characteristics on persons who use drugs pursuit of care for hepatitis C virus infection.
Williams N; Bossert N; Chen Y; Jaanimägi U; Markatou M; Talal AH
J Subst Abuse Treat; 2019 Jul; 102():33-39. PubMed ID: 31202286
[TBL] [Abstract][Full Text] [Related]
11. Retention in buprenorphine treatment is associated with improved HCV care outcomes.
Norton BL; Beitin A; Glenn M; DeLuca J; Litwin AH; Cunningham CO
J Subst Abuse Treat; 2017 Apr; 75():38-42. PubMed ID: 28237052
[TBL] [Abstract][Full Text] [Related]
12. A novel mHealth application for improving HIV and Hepatitis C knowledge in individuals with opioid use disorder: A pilot study.
Ochalek TA; Heil SH; Higgins ST; Badger GJ; Sigmon SC
Drug Alcohol Depend; 2018 Sep; 190():224-228. PubMed ID: 30056321
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C Virus Incidence in a Cohort in Medication-Assisted Treatment for Opioid Use Disorder in New York City.
Jordan AE; Cleland CM; Wyka K; Schackman BR; Perlman DC; Nash D
J Infect Dis; 2020 Sep; 222(Suppl 5):S322-S334. PubMed ID: 32877567
[TBL] [Abstract][Full Text] [Related]
14. Screening and evaluation of hepatitis C virus infection in pregnant women on opioid maintenance therapy: A retrospective cohort study.
Krans EE; Zickmund SL; Rustgi VK; Park SY; Dunn SL; Schwarz EB
Subst Abus; 2016; 37(1):88-95. PubMed ID: 26569631
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C infection, related services, and barriers to HCV treatment among drug users in methadone maintenance treatment (MMT) clinics in Shanghai, China.
Li ZB; Zhang L; Wang J; Huang LP; Zhou ZR; Cao YN; Zhao M; Du J
Harm Reduct J; 2017 Nov; 14(1):71. PubMed ID: 29096647
[TBL] [Abstract][Full Text] [Related]
16. Peer involvement and cross-sector efforts in establishing integrated treatment of hepatitis C virus infection for people with substance use disorders: experiences from Norway.
Lygren OJ; Bjørnestad R; Løberg EM; Bonnier ML; Buljovcic VB; Johansson KA; Fadnes LT;
Subst Abuse Treat Prev Policy; 2019 Dec; 14(1):58. PubMed ID: 31864396
[TBL] [Abstract][Full Text] [Related]
17. Test uptake and hepatitis C prevalence in 5483 Danish people in drug use treatment from 1996 to 2015: a registry-based cohort study.
Øvrehus A; Nielsen S; Hansen JF; Holm DK; Christensen P
Addiction; 2019 Mar; 114(3):494-503. PubMed ID: 30347471
[TBL] [Abstract][Full Text] [Related]
18. Perinatal Transmission of Hepatitis C Virus: Defining the Cascade of Care.
Epstein RL; Sabharwal V; Wachman EM; Saia KA; Vellozzi C; Hariri S; Linas BP
J Pediatr; 2018 Dec; 203():34-40.e1. PubMed ID: 30170857
[TBL] [Abstract][Full Text] [Related]
19. Viral Hepatitis and Human Immunodeficiency Virus Testing and Linkage to Care for Individuals Enrolled in an Opioid Treatment Program.
Rowan SE; Kamis KF; Beum R; Bryan K; Gawenus L; Colon Sanchez D; Hurley H
J Infect Dis; 2020 Sep; 222(Suppl 5):S384-S391. PubMed ID: 32877565
[TBL] [Abstract][Full Text] [Related]
20. Initiation of Low-threshold Buprenorphine in Nontreatment Seeking Patients With Opioid Use Disorder Engaged in Hepatitis C Treatment.
Hill K; Nussdorf L; Mount JD; Silk R; Gross C; Sternberg D; Bijole P; Jones M; Kier R; Mccullough D; Mathur P; Kottilil S; Masur H; Kattakuzhy S; Rosenthal ES
J Addict Med; 2022 Jan-Feb 01; 16(1):10-17. PubMed ID: 33560694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
